Clinical Trial Update: Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial Update for M5049 in participants with COVID-19 pneumonia (ANEMONE) has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• M5049

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Coronavirus Disease 2019 | Phase 2 | Status: COMPLETED | Results posted: 2022-06-06